Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment. | Pharmaceutics;14(11)2022 Oct 25. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment.

Zheng, Run; Ma, Jian.

Affiliation

Zheng R; NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Ma J; Cancer Research Institute and School of Basic Medical Science, Central South University, Changsha 410078, China.

Pharmaceutics ; 14(11)2022 Oct 25.

Article in En | MEDLINE | ID: mdl-36365103

Key words

cancer immunotherapy; combination therapy; toll-like receptors; tumor microenvironment; vaccine adjuvant

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceutics Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceutics Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland